Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Saredutant add-on to escitalopram for major depressive disorder
2007-003159-36Phase 3Completed
- Sponsor
- Sanofi
- Start
- Aug 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of saredutant, escitalopram in major depressive disorder (MDD), sponsored by Sanofi. Started Aug 2007; status: completed.
02
Drugs
saredutantescitalopram
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on 2007-003159-36.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-003159-36.